FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2026/03/106301 [Registered on: 16/03/2026] Trial Registered Prospectively
Last Modified On: 16/03/2026
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Ayurveda 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   A study to compare the effect of Polyherbal combination made from Brahmi, Shankhpushpi, and Vacha with Tagar powder in improving sleep in people suffering from insomnia. 
Scientific Title of Study   Effectiveness of a polyherbal churn formulation of Bramhi, Shankhpushpi and Vacha compared to Tagar churn in the management of Anidra (Primary insomnia):A Randomised Controlled Clinical Trial 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Nikita Gajanan Deulkar 
Designation  PG Scholar 
Affiliation  Shri Ayurved Mahavidyalaya, Nagpur 
Address  OPD 1, Kayachikitsa Department, Pakwasa Samnvay Rugnalaya, Shri Ayurved Mahavidyalaya, Hanuman Nagar, Nagpur.

Nagpur
MAHARASHTRA
440024
India 
Phone  9405950854  
Fax    
Email  nikitagdeulkar@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Archana Dachewar 
Designation  HOD and Professor 
Affiliation  Shri Ayurved Mahavidyalaya, Nagpur 
Address  OPD 1, Kayachikitsa Department, Pakwasa Samnvay Rugnalaya, Shri Ayurved Mahavidyalaya, Hanuman Nagar, Nagpur.

Nagpur
MAHARASHTRA
440024
India 
Phone  9822206312  
Fax    
Email  dr.dachewar@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Nikita Gajanan Deulkar 
Designation  PG Scholar 
Affiliation  Shri Ayurved Mahavidyalaya, Nagpur 
Address  OPD 1, Kayachikitsa Department, Pakwasa Samnvay Rugnalaya, Shri Ayurved Mahavidyalaya, Hanuman Nagar, Nagpur.

Nagpur
MAHARASHTRA
440024
India 
Phone  9405950854  
Fax    
Email  nikitagdeulkar@gmail.com  
 
Source of Monetary or Material Support  
Shri Ayurved Mahavidyalaya, Hanuman Nagar, Nagpur 440024, Maharashtra, India 
 
Primary Sponsor  
Name  Dr Nikita Gajanan Deulkar 
Address  OPD 1, Kayachikitsa Department, Pakwasa Samnvay Rugnalaya, Shri Ayurved Mahavidyalaya, Hanuman Nagar, Nagpur 440024, Maharshtra, India. 
Type of Sponsor  Other [Self] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Nikita Deulkar  Shri Ayurved Mahavidyalaya, Nagpur  OPD 1, Kayachikitsa Department, Pakwasa Samnvay Rugnalaya, Shri Ayurved Mahavidyalaya, Hanuman Nagar, Nagpur.
Nagpur
MAHARASHTRA 
9405950854

nikitagdeulkar@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethics Committee, Shri Ayurved Mahavidyalaya, Nagpur  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:F510||Insomnia not due to a substance orknown physiological condition. Ayurveda Condition: NIDRANASAH/ASVAPNAH,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Intervention ArmDrugClassical(1) Medicine Name: Polyherbal combination, Reference: hmi - Dash B, SharmBraa RK. Charaka Samhita (Text with English Translation). Varanasi: Chowkhamba Sanskrit Series; 2001. Shankhpushi - 16) Nadkarni KM. Indian Materia Medica. Bombay: Popular Prakashan; 2009. Vacha- 20) Sharma PV. Dravyaguna Vijnana, Vol. 2. Varanasi: Chaukhamba Bharti Academy; 2003., Route: Oral, Dosage Form: Churna/ Powder, Dose: 4(g), Frequency: bd, Bhaishajya Kal: Adhobhakta, Duration: 30 Days, anupAna/sahapAna: Yes(details: -Milk), Additional Information: Polyherbal combination contains Brahmi Churna (1.875 gms), Shankhapushi Churna (1.875 gms), Vacha Churna(0.250 gms)
2Comparator ArmDrugClassical(1) Medicine Name: Tagar Churna, Reference: 24) Sharma PV. Dravyaguna Vigyan, Vol. II. 2nd ed. Varanasi: Chaukhambha Bharati Academy; 2006. p. 694-696., Route: Oral, Dosage Form: Churna/ Powder, Dose: 4(g), Frequency: bd, Bhaishajya Kal: Adhobhakta, Duration: 30 Days, anupAna/sahapAna: Yes(details: -Milk), Additional Information: -
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  60.00 Year(s)
Gender  Both 
Details  1. Patients aged between 18 and 60 years
2. Diagnosed cases of Primary Insomnia based on Diagnostic and Statistical Manual of Mental Disorders-Fifth Edition (DSM-IV)
3. AIS score more than or equal to 6 at baseline.
4. Duration of insomnia more than or equal to 1 month
5. Willingness to participate and provide written informed consent
 
 
ExclusionCriteria 
Details  Secondary insomnia due to psychiatric disorders (e.g., depression, anxiety) or medical conditions.
History of substance abuse or sedative use within the past 2 weeks.
Severe hepatic, renal, or cardiovascular illness.
Pregnant or lactating women.
Known allergy to trial drugs or their components.
Known case of Lactose Intolerance.
 
 
Method of Generating Random Sequence   Stratified block randomization 
Method of Concealment   On-site computer system 
Blinding/Masking   Participant and Investigator Blinded 
Primary Outcome  
Outcome  TimePoints 
This study may provide improvement in sleep quality assessed by the Athens Insomnia Scale (AIS) score from baseline to after 30 days of treatment.  At the end of 30 days (7th, 15th, 30th days) 
 
Secondary Outcome  
Outcome  TimePoints 
Change in severity of associated symptoms (Angamarda, Shirogaurava, Glani, and Jrumbha) before and after 30 days of treatment.  At the end of 30 days (7th, 15th, 30th days) 
 
Target Sample Size   Total Sample Size="80"
Sample Size from India="80" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 3 
Date of First Enrollment (India)   27/03/2026 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  
This study will be carried out at OPD and IPD of Kayachikitsa Department of Pakwasa Samanvay Rugnalaya, Shri Ayurved Mahavidyalaya, Nagpur.
This is a double-blind randomized controlled trial aims at studying the comparison between polyherbal churna formulation of bramhi shankhpushpi and vacha with tagar churna in management of Anidra (primary insomnia.)
A total of 80 patients will be included and will be randomly allocated to two treatment groups using Stratified block randomization method i.e. Group A and Group B each containing 40
patients. Group A will be trial group, where patients will receive polyherbal churna(bramhi , shankhapushpi and vacha )and Group B will be the control group, where patients will receive Tagar Churna. Then patients will be
observed on 7th, 15th, and 30th day. All the findings will be recorded in case record form. At the end of trial, collected data will be analyzed and results will be drawn accordingly.
 
Close